MYelin Disorders REseArch teaM (MYDREAM), Liège, Belgium Department of Neurology, C.H.U. of Liège, Liège, Belgium.
NeuroRehabilitation. 2012;30(4):261-6. doi: 10.3233/NRE-2012-0754.
No clinical test is currently available and validated to measure the maximum walking speed (WS) of multiple sclerosis (MS) patients. Since the Timed 25-Foot Walk Test (T25FW) is performed with a static start, it takes a significant proportion of the distance for MS patients to reach their maximum pace.
In order to capture the maximum WS and to quantify the relative impact of the accelerating phase during the first meters, we compared the classical T25FW with a modified version (T25FW(+)allowing a dynamic start after a 3 meters run-up.
Sixty-four MS patients and 30 healthy subjects performed successively the T25FW and the T25FW(+).
The T25FW(+)was performed faster than the T25FW for the vast majority of MS and healthy subjects. In the MS population, the mean relative gain of speed due to the dynamic start on T25FW(+) was independent from the EDSS and from the level of ambulation impairment. Compared to healthy subjects, the relative difference between dynamic versus static start was more important in the MS population even in patients devoid of apparent gait impairment according to the T25FW.
The T25FW(+)allows a more accurate measurement of the maximum WS of MS patients, which is a prerequisite to reliably evaluate deceleration over longer distance tests. Indirect arguments suggest that the time to reach the maximum WS may be partially influenced by the cognitive impairment status. The maximum WS and the capacity of MS patients to accelerate on a specific distance may be independently regulated and assessed separately in clinical trials and rehabilitation programs.
目前尚无临床测试可用于测量多发性硬化症(MS)患者的最大步行速度(WS),且经过验证。由于定时 25 英尺步行测试(T25FW)采用静态起步,因此 MS 患者需要相当一部分距离才能达到最大步速。
为了捕捉最大 WS 并量化最初几米加速阶段的相对影响,我们比较了经典的 T25FW 和改良版本(T25FW(+)),后者允许在 3 米起跑后进行动态起步。
64 名 MS 患者和 30 名健康受试者依次进行 T25FW 和 T25FW(+)测试。
对于绝大多数 MS 和健康受试者,T25FW(+)的表现速度明显快于 T25FW。在 MS 人群中,由于 T25FW(+)的动态起步而导致的速度相对增益与 EDSS 和步行障碍程度无关。与健康受试者相比,即使根据 T25FW 没有明显步态障碍的 MS 患者,动态与静态起步之间的相对差异在 MS 人群中更为重要。
T25FW(+)可更准确地测量 MS 患者的最大 WS,这是可靠评估更长距离测试中减速的前提。间接证据表明,达到最大 WS 的时间可能部分受到认知障碍状态的影响。最大 WS 和 MS 患者在特定距离内加速的能力可能在临床试验和康复计划中独立调节和评估。